Eyal Attar
Chief Tech/Sci/R&D Officer at VOR BIOPHARMA INC.
Net worth: 262 485 $ as of 2024-03-30
Profile
Eyal C.
Attar is currently the Chief Medical Officer at Vor Biopharma, Inc. Prior to this, he worked as the Senior Medical Director at Agios Pharmaceuticals, Inc. from 2016 to 2019.
He also served as the Chief Medical Officer & Senior Vice President at Aprea Therapeutics, Inc. Dr. Attar's education includes a doctorate degree from UNC School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VOR BIOPHARMA, INC.
0.16% | 2024-05-05 | 110,708 ( 0.16% ) | 262 378 $ | 2024-03-30 |
APREA THERAPEUTICS, INC.
0.00% | 2023-06-25 | 16 ( 0.00% ) | 107 $ | 2024-03-30 |
Eyal Attar active positions
| Companies | Position | Start |
|---|---|---|
| VOR BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 2022-10-11 |
Former positions of Eyal Attar
| Companies | Position | End |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
| Harvard Medical School | Corporate Officer/Principal | - |
| APREA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Eyal Attar
| UNC School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Eyal Attar
